BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 18721776)

  • 1. Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program.
    MacMillan ML; Davies SM; Nelson GO; Chitphakdithai P; Confer DL; King RJ; Kernan NA
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):16-22. PubMed ID: 18721776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program.
    Karanes C; Nelson GO; Chitphakdithai P; Agura E; Ballen KK; Bolan CD; Porter DL; Uberti JP; King RJ; Confer DL
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):8-15. PubMed ID: 18721775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The national marrow donor program 20 years of unrelated donor hematopoietic cell transplantation.
    Ballen KK; King RJ; Chitphakdithai P; Bolan CD; Agura E; Hartzman RJ; Kernan NA
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):2-7. PubMed ID: 18721774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program.
    Miller JP; Perry EH; Price TH; Bolan CD; Karanes C; Boyd TM; Chitphakdithai P; King RJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):29-36. PubMed ID: 18721778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donation activities and product integrity in unrelated donor allogeneic hematopoietic transplantation: experience of the National Marrow Donor Program.
    Bolan CD; Hartzman RJ; Perry EH; Trainor L; Miller J; Miller R; Hanley L; Chitphakdithai P; King RJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):23-8. PubMed ID: 18721777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program.
    Perkins HA; Kollman C; Howe CW
    Clin Transpl; 1994; ():295-301. PubMed ID: 7547550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry.
    Spellman S; Setterholm M; Maiers M; Noreen H; Oudshoorn M; Fernandez-Viña M; Petersdorf E; Bray R; Hartzman RJ; Ng J; Hurley CK
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):37-44. PubMed ID: 18721779
    [No Abstract]   [Full Text] [Related]  

  • 9. National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants.
    Bray RA; Hurley CK; Kamani NR; Woolfrey A; Müller C; Spellman S; Setterholm M; Confer DL
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):45-53. PubMed ID: 18721780
    [No Abstract]   [Full Text] [Related]  

  • 10. The National Marrow Donor Program: improving access to hematopoietic stem cell transplantation.
    Dodson KL; Coppo PA; Confer DL
    Clin Transpl; 1999; ():121-7. PubMed ID: 11038630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cord blood transplantation for children with acute leukaemia: a Eurocord registry analysis.
    Gluckman E; Rocha V
    Blood Cells Mol Dis; 2004; 33(3):271-3. PubMed ID: 15528143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marrow and stem cell transplantation in Oklahoma: fifteen years of experience and results.
    Mandanas RA; Carter TH; Epstein RB; Roy V; Selby GB
    J Okla State Med Assoc; 1998 Sep; 91(6):339-46. PubMed ID: 9763768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor selection process for allogeneic hematopoietic stem cell transplantation at the university hospital of Düsseldorf (1997-1998).
    Enczmann J; Rinker M; Kiesel U; Kuhröber A; Kögler G; Nürnberger W; Göbel U; Wernet P
    Klin Padiatr; 1999; 211(4):218-23. PubMed ID: 10472554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell transplantation: past, present and future.
    Thomas ED
    Stem Cells; 1994 Nov; 12(6):539-44. PubMed ID: 7881356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell source and outcome after hematopoietic stem cell transplantation (HSCT) in children and adolescents with acute leukemia.
    Peters C; Cornish JM; Parikh SH; Kurtzberg J
    Pediatr Clin North Am; 2010 Feb; 57(1):27-46. PubMed ID: 20307710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unrelated donor stem cell transplantation: the role of the National Marrow Donor Program.
    Karanes C; Confer D; Walker T; Askren A; Keller C
    Oncology (Williston Park); 2003 Aug; 17(8):1036-8, 1043-4, 1164-7. PubMed ID: 12966671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research.
    Lazarus HM; Pérez WS; Klein JP; Kollman C; Bate-Boyle B; Bredeson CN; Gale RP; Geller RB; Keating A; Litzow MR; Marks DI; Miller CB; Douglas Rizzo J; Spitzer TR; Weisdorf DJ; Zhang MJ; Horowitz MM
    Br J Haematol; 2006 Mar; 132(6):755-69. PubMed ID: 16487177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies.
    Kanda J; Ichinohe T; Matsuo K; Benjamin RJ; Klumpp TR; Rozman P; Blumberg N; Mehta J; Sohn SK; Uchiyama T
    Transfusion; 2009 Apr; 49(4):624-35. PubMed ID: 19170998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.